News
The FDA has expanded the approval of Dextenza (dexamethasone ophthalmic insert) to include pediatric treatment.
Dextenza is an intracanalicular insert that delivers a 0.4mg dose of dexamethasone, a corticosteroid, for up to 30 days following insertion.
Discover the main types of pink eye, their symptoms, treatments, and prevention tips for both children and adults in this ...
While these drugs are available over the counter in the United States, it’s recommended that you consult your doctor for a ...
ABC News medical correspondent Dr. Darien Sutton answers your health questions and shares tips for recognizing food allergies ...
The white fluff floating in the air like snow is causing problems for many, as it tends to trap allergens such as pollen and ...
Surprisingly, to these sufferers when their eyes are involved, they are often experiencing allergic conjunctivitis. Allergic conjunctivitis is an inflammation (-itis) of the mucosal membrane ...
12d
GlobalData on MSNDesentum to advance pollen allergy vaccine after positive Phase I trialThe company’s Phase I trial saw nearly all patients in the trial reaching their targeted maximum dose of DM-101PX.
Hosted on MSN21d
Allergic Conjunctivitis: Everything You Need to KnowAllergic conjunctivitis (AC) is eye inflammation caused by a reaction to an allergen, such as pollen or mold spores. Exposure to allergens can cause the eyes to become red, watery, and itchy.
Aldeyra Therapeutics, Inc.’s ALDX share price has surged by 12.83%, which has investors questioning if this is right time to sell.
With allergy season lasting longer and pollen levels rising, it's more important than ever to manage your symptoms and find ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results